Carina Biotech products

Carina Biotech`s proprietary manufacturing process leads to a greater efficiency in CAR-T cell manufacturing.

Antigen-binding domain, Optimised linker domain, CD8-derived transmembrane domain, 4-1BB co-stimulatory domain, CD3 zeta stimulatory domain, Engineered chemokine receptor

Advanced colorectal cancer currently has a poor prognosis and is the deadliest form of cancer for Australians 25 to 34 years old. LGR5 is a cancer stem cell marker that is highly expressed on advanced colorectal cancer and other cancers. In colon cancer patients, LGR5+ expression has been correlated with a particularly poor prognosis.